Radiopharmaceuticals / Radiochemistry

The CU Research Imaging Center utilizes a radiochemistry laboratory at PharmaLogic LLC facility. The department offers Nuclear Medicine expertise and support for collaboration on the specific needs for any radiochemistry portion of human subject protocols. 

Radiopharmaceuticals currently available are:

• FDG
• ¹¹C Acetate
• ¹¹C PiB
• ⁶⁸Ga PSMA

PharmaLogic operates a GE PETTrace cyclotron that produces PET radioisotopes for the manufacturing and distribution of clinical and research PET radiopharmaceuticals. The close proximity of the CU-RIC to PharmaLogic within the Bioscience 3 building allows delivery and use of the very short-lived PET radioisotopes. For example, ¹⁵O-labeled oxygen, having a radioactive half-life of 2 minutes, can be delivered within tubing directly from the cyclotron to the PET/CT or PET/MR scanner in a few tens of seconds. A wide range of PET radioisotopes and radiopharmaceuticals are available. PharmaLogic has a network of cyclotron radiopharmacies across the US to facilitate multicenter clinical trials with new PET radiopharmaceuticals or use of PET imaging in conjunction with novel drug therapies. A research radiochemistry lab is available for novel PET radiopharmaceutical development.